Head-to-head · WeighScore
Fierce Health vs Recovery Delivered
The verdict
Recovery Delivered takes it — 60.7/100 to 56.6/100.
Recovery Delivered grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Recovery Delivered is a US telehealth service (Tara Healthcare LLC) that offers compounded GLP-1 weight-loss medication alongside its addiction-recovery care.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Fierce Health | Recovery Delivered |
|---|---|---|
| WeighScore | 56.6/100 | 60.7/100 |
| Grade | C | C |
| Scorecard rank | #411 | #318 |
| Semaglutide | $297/mo (3-month plan, compounded) | $199/mo (starting dose, compounded) |
| Tirzepatide | $497/mo (3-month plan, compounded) | $219/mo (2.5 mg dose, compounded) |
| Coverage | 30 states | 32 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #411 · C
Strengths
- 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer on every product page
- Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
- Microdose tier at $197/mo is one of the lower entry points we've seen
Where it loses points
- No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
- Operating LLC name not disclosed anywhere on the site
- Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
- Clinical provider network not named
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Graded #318 · C
Strengths
- Low entry price: compounded semaglutide from $199.99/mo, tirzepatide from $219/mo
- Video visit with a provider and home delivery included in the price
- Offers both injectable and oral compounded GLP-1 options
Where it loses points
- Compounding pharmacy is not publicly named
- Not available in 19 states (including CA, IL, TN, GA, MI)
- Higher semaglutide doses cost up to $299.99/mo
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.